|
Originally published In Press as doi:10.1074/jbc.M112105200 on January 24, 2002
J. Biol. Chem., Vol. 277, Issue 15, 13091-13098, April 12, 2002
Characterization of a Novel Drosophila melanogaster
Galectin
EXPRESSION IN DEVELOPING IMMUNE, NEURAL, AND MUSCLE TISSUES*
Karen E.
Pace ,
Tim
Lebestky§,
Thomas
Hummel¶,
Pascal
Arnoux ,
Kent
Kwan , and
Linda G.
Baum §**
From the Department of Pathology and Laboratory
Medicine, § Molecular Biology Institute, ¶ Howard
Hughes Medical Institute, UCLA, Los Angeles, California 90095 and
Department of Molecular and Medical Genetics, University of
Toronto, Toronto, Ontario M5S 1A8, Canada
Received for publication, December 18, 2001, and in revised form, January 24, 2002
 |
ABSTRACT |
We have cloned and characterized the first
galectin to be identified in Drosophila melanogaster. The
amino acid sequence of Drosophila galectin showed striking
sequence similarity to invertebrate and vertebrate galectins and
contained amino acids that are crucial for binding -galactoside
sugars. Confirming its identity as a galectin family member, the
Drosophila galectin bound -galactoside sugars.
Structurally, the Drosophila galectin was a tandem repeat galectin containing two carbohydrate recognition domains connected by a
unique peptide link. This divalent structure suggests that like
mammalian galectins, Drosophila galectin may mediate
cell-cell communication or facilitate cross-linking of receptors to
trigger signal transduction events. The Drosophila
galectin was very abundant in embryonic, larval, and adult
Drosophila. During embryogenesis, Drosophila
galectin had a unique and specific tissue distribution. Drosophila galectin expression was concentrated in somatic
and visceral musculature and in the central nervous system. Similar to
other insect lectins, Drosophila galectin may function in
both embryogenesis and in host defense. Drosophila galectin
was expressed by hemocytes, circulating phagocytic cells, suggesting a
role for Drosophila galectin in the innate immune system.
 |
INTRODUCTION |
Many biological processes have been elucidated using
Drosophila melanogaster as a model system. However, little
is known about lectin-ligand interactions in Drosophila. Of
the few Drosophila lectins that have been identified, a
subset has been shown to be vital in embryogenesis and to function in
innate immunity (1-5).
In embryonic Drosophila, two lectins, gliolectin and a
selectin homologue, have been identified and determined to play a role in embryogenesis (4, 5). Gliolectin mediates cell-cell interactions that may be required for the formation of axonal commissures during nervous system development (4). Mutations in the selectin homologue lead to profound defects in eye and mechanosensory bristle development (5). Stage-specific regulation of the expression of specific glycoconjugates also occurs during Drosophila development,
further suggesting important developmental roles for lectins
(6-10).
Other lectins may have functions beyond development (1-3, 11). In
larval and adult Drosophila, a C-type lectin has been identified (3). The expression of this C-type lectin is up-regulated following injury, suggesting that it has a role in the innate immune
system. Other insects rely on lectins for recognition and phagocytosis
of invading microorganisms and for the modulation of hemocyte
aggregation during an immune response (1, 2, 11-13). Because
Drosophila express diverse and complex oligosaccharide structures whose expression is spatially and temporally regulated (6),
it is likely that these structures are recognized by additional specific lectins that remain to be identified. In support of this, a
BLAST analysis of the Berkeley Drosophila Genome Project
with consensus sequences from various lectin families has identified at
least 21 putative Drosophila lectins, including a possible galectin homologue (6, 14, 15).
Galectins are an evolutionarily conserved lectin family that have been
identified in mammals, birds, amphibians, reptiles, fish, nematodes,
marine sponges, and multicellular fungi (15, 16). In some species there
are a large number of galectin family members; 13 galectins have been
identified in mammals (15, 17-19). However, a galectin homologue has
not been definitively identified in D. melanogaster (15). In
vertebrates, galectins are involved in a variety of cellular processes
that determine cell fate, by mediating cell-cell interactions, inducing
cell proliferation, or regulating cell death (20-23). For example,
during mammalian brain development, galectin-1 promotes olfactory
neuron fasciculation by cross-linking adjacent axons and promoting
axonal adhesion to the extracellular matrix (24, 25). Galectins also
maintain vertebrate immune system homeostasis and may be a vital
component of the innate immune system in insects and mammals (12, 20, 22, 23, 26-28).
Given the large number of mammalian galectins, genetic approaches in
mice may not elucidate all of the functions of specific galectins. The
facile genetic analysis that is possible in Drosophila and
the apparently small number of putative galectins in the
Drosophila genome would simplify the examination of in
vivo functions of galectins. We have cloned and characterized the
first identified Drosophila galectin
(Dmgal),1 and we have
examined its distribution during embryogenesis and in the immune system.
 |
EXPERIMENTAL PROCEDURES |
Generation of Full-length Dmgal cDNA--
To obtain a
complete cDNA sequence, 3'-rapid amplification of cDNA ends
(3'-RACE) was performed. 3'- and 5'-RACE-Ready cDNA was synthesized
from larval poly(A)+ RNA (CLONTECH,
Palo Alto, CA) using the SMART RACE cDNA Amplification kit
according to the manufacturer's instructions
(CLONTECH). For 5'- and 3'-RACE, a gene-specific
primer (GSP1) was designed against a region of the
expressed sequence tag (EST) (LP06039.5prime (15)) encoding a
highly conserved amino acid sequence critical to saccharide binding.
Touchdown PCR was performed with
GSP1:GAGATGTGGCGCTCCACATTAATCCA according to
manufacturer's instructions with the addition of a final cycle at
72 °C for 7 min to create poly(A) tails necessary for TOPO TA
cloning. The PCR product was subcloned into the pCR4 TOPO vector
(Invitrogen, Carlsbad, CA) and was sequenced by the Davis Sequencing
Facility (Davis, CA). To ensure that the entire sequence was obtained,
three additional GSPs were designed 174, 255, and 320 bp, respectively,
downstream of GSP1. 3'-RACE was performed, the products
subcloned into the pCR4 TOPO vector, and sequenced as described above.
To generate full-length cDNA, long distance PCR was performed with
primers designed from the extreme 5' and 3' ends of the cDNA and
5'-RACE-Ready cDNA as a template, using the Advantage cDNA PCR
kit according to the manufacturer's instructions
(CLONTECH). A final 12-min cycle at 72 °C was
added to create poly(A) tails. The entire cDNA sequence was
subcloned directly into the pTrcHis2 TOPO expression vector
(Invitrogen) and sequenced to ensure orientation and completeness.
Expression of Recombinant Dmgal--
Dmgal cDNA lacking a
stop codon was subcloned into the pTrcHis2 TOPO expression vector to
express the recombinant Drosophila protein with a C-terminal
Myc-His tag. TOP10 One Shot cells (Invitrogen) were transformed with
the expression vector and were induced to express recombinant protein
with 1 mM
isopropyl-1-thio- -D-galactopyranoside for 4 h. The
cells were harvested by centrifugation at 8000 rpm for 10 min. The cell
pellet was lysed with B-PER (Bio-Rad) containing 4 mM
dithiothreitol (DTT, Sigma) for 10 min at 4 °C, followed by
centrifugation at 10,000 rpm for 20 min. The bacterial supernatant was
loaded directly on a -lactosyl-Sepharose affinity column prepared as
described previously (29) or a control fucosyl-Sepharose (Sigma)
affinity column. The recombinant protein was not purified over a nickel
column prior to carbohydrate affinity chromatography because this type
of purification has been shown be ineffective for isolating active
galectin-1.2 The carbohydrate
affinity column was washed extensively with Ca2+,Mg2+-free phosphate-buffered saline, 4 mM DTT, 0.02% sodium azide (wash buffer). Bound proteins
were eluted with 0.1 M -lactose or 0.1 M
fucose dissolved in wash buffer. Eluted fractions were separated by
10% SDS-PAGE and transferred to nitrocellulose for Western blotting.
Isolation and Purification of Native Dmgal--
Wild type
embryonic, third instar larval, and adult Drosophila were
Dounce-homogenized in phosphate-buffered saline, 4 mM DTT,
1 mM phenylmethylsulfonyl fluoride, 0.1 M
-lactose (30). The homogenate was rotated for 30 min at 4 °C, and
soluble proteins were collected following centrifugation at 10,000 × g for 10 min at 4 °C. A protein assay (Bio-Rad) was
performed, and known quantities of homogenate were separated by 10%
SDS-PAGE and transferred to nitrocellulose for Western blotting.
To purify native Dmgal, 8.8 mg of protein homogenate from third instar
larvae and adult Drosophila was obtained as described above.
The protein homogenate was loaded directly onto a -lactosyl column,
washed with wash buffer, and eluted with 0.1 M -lactose. Eluted proteins were separated by 10% SDS-PAGE and transferred to
nitrocellulose for Western blotting. To evaluate the binding of Dmgal
to -lactosyl-Sepharose, the adult protein homogenate prior to
purification over the lactose column, the unbound fraction, and the
bound fraction were analyzed by 10% SDS-PAGE followed by Coomassie
Blue staining, Western blotting, and protein assay (Bio-Rad).
Northern Blot Analysis--
Northern blot hybridization was
performed with 2.5 µg of poly(A)+ RNA from embryonic,
larval, and adult Drosophila (CLONTECH)
and Dmgal cDNA as a probe. The Dmgal probe was labeled with
[ -32P]dCTP using a random primer labeling kit
(Amersham Biosciences). Hybridization was performed in Rapid-Hyb
hybridization buffer (Amersham Biosciences) for 1.5 h at 68 °C.
Stringency washes were performed at 25, 42, and 68 °C using standard
procedures and checked by autoradiography between each stringency wash.
Similar results were obtained for each stringency wash.
Immunoblotting--
Western blotting was performed using
standard immunoblotting techniques followed by enhanced
chemiluminescence for protein visualization. Antibody concentrations
were as follows: rabbit anti-human galectin-1 polyclonal antiserum
(1/1000), horseradish-peroxidase-conjugated anti-His antibody (1/4000;
Invitrogen), horseradish peroxidase-conjugated goat anti-rabbit
antibody (1/6000; Bio-Rad).
In Situ Hybridization--
Full-length digoxigenin-labeled RNA
probes were prepared from the pSPUTK vector (Stratagene, La Jolla, CA)
containing full-length Dmgal cDNA. The vector was linearized
upstream of the insert with NheI and downstream of the
insert with HpaI. Sense and antisense digoxigenin-labeled RNAs were produced using the SP6 and T7 RNA polymerases according to the manufacturer's directions (Roche Molecular Biochemicals). The probes were base-hydrolyzed for 30 min to
generate ~200-base pair fragments. An overnight collection of
Drosophila embryos was dechorionated and fixed with 10%
paraformaldehyde. In situ hybridization was performed using
standard procedures and visualized with
alkaline-phosphatase-conjugated anti-digoxigenin antibody
(1/2000; Roche Molecular Biochemicals).
Immunohistochemistry--
Smears of circulating hemocytes from
third instar hemolymph were formed by cutting larvae with tweezers and
spreading the hemolymph on a glass slide. The smears were fixed,
permeabilized, and immunostained exactly as described previously (31).
Polyclonal rabbit anti-human galectin-1 antibody was used at a
concentration of 1/500 and goat anti-rabbit-fluorescein (Jackson
ImmunoResearch, West Grove, PA) was used at a concentration of 1/100.
Images were collected on a Olympus Flowview confocal microscope with
the ×100 objective and analyzed with Fluoview Image Analysis software
(version 2.1.39)
 |
RESULTS |
Isolation of Dmgal cDNA--
A partial EST with amino acid
sequence similarity to the carbohydrate recognition domain of galectin
family members was identified (15). To isolate the entire cDNA, 5'-
and 3'-RACE were performed using gene-specific primers directed against
the segments that showed greatest similarity to galectin, and
Drosophila larval poly(A)+ RNA as a template.
The Dmgal gene is located on chromosome 2L, 21A5 (32). The deduced
amino acid sequence encoded by the complete cDNA is shown in Fig.
2.
The amino acid sequence contained important elements that are required
for a protein to be defined as a galectin family member (33).
Specifically, Dmgal contained two domains that had sequence similarity
to the canonical carbohydrate recognition domains (CRD) of galectin
family members (Fig. 1). Both CRDs
contained the conserved sequence motifs H-NPR and WG-ER that are
important for the binding of galectins to -galactoside sugars (Fig.
1) (34), in contrast to the mammalian tandem repeat galectin,
galectin-12, in which only one CRD contained these sequence motifs
(18). The two CRDs were connected by a unique peptide link that had
some sequence similarity to the peptide link of galectin-9. This
structural organization classifies Dmgal into the group of tandem
repeat-type galectins that contain two CRDs connected by a unique
peptide link (35). Fig. 1 depicts the Dmgal CRD organization that was derived following comparison of Dmgal with known mammalian galectin sequences and structures and by sequence comparison between each CRD. Other galectins that are classified in the tandem repeat family
are galectins-4, -6, -8, -9, and -12 and the Caenorhabditis elegans 32-kDa galectin (18, 35-39).

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 1.
A schematic of the structural domains of
Dmgal. Conserved amino acids that are involved in carbohydrate
recognition are denoted by an asterisk. Differences in amino
acids are underlined.
|
|
Examination of the CRDs of Dmgal suggested that each domain may differ
with respect to the ability to bind sugar ligands. In the N-terminal
CRD (CRD I), there was an Arg to Val substitution at amino acid 206. In
most galectin family members this Arg stabilizes galectin-carbohydrate
interactions (40). However, in other galectins this Arg is substituted
with Lys (galectin-4, Xenopus galectin), Ile (galectin-8),
and His (sponge galectin I), and these galectins retain the ability to
bind -galactoside sugars (36, 37, 41, 42). In CRD II there is a Val
to Cys substitution at amino acid 406. This amino acid is also
substituted with Gln and Ile in Conger eel Lec1 and C. elegans 32-kDaa galectin, respectively. Interestingly, CRD I had the highest sequence similarity to galectin-4, -5, and -9, and CRD II had the highest sequence similarity to galectin-4 (36, 38,
39); differences between CRD similarity are also seen in the tandem
repeat galectin-12 (18).
Characteristic of galectin family members, the amino acid sequence of
Dmgal did not contain a classical secretion signal peptide or a
transmembrane domain (33). However, the sequence did contain a
120-amino acid N-terminal domain that is not found in other galectins
and shows no significant sequence identity with any other known protein
(Fig. 1). This domain is likely to adopt a secondary helical structure
(43). Characteristic of galectins, Dmgal did not contain a
Ca2+ binding domain.
Dmgal showed significant amino acid sequence similarity to galectin
family members from various species (identity 23-35%). The alignment
of Dmgal with galectins from selected species and the computation of
sequence identities and similarity groups were generated using Genedoc
(version 2.6.001) and ClustalX (version 1.8) (35, 36, 44-46) (Fig.
2). Dmgal had a great deal of sequence similarity with human galectin-4 and murine galectin-9, which are also
tandem repeat galectins (38, 44). Interestingly, the similarity with
these two mammalian tandem repeat galectins was slightly greater than
that with the C. elegans tandem repeat galectin,
demonstrating the strong conservation across vertebrate and
invertebrate species.

View larger version (67K):
[in this window]
[in a new window]
|
Fig. 2.
Amino acid sequence alignment of galectin
family members from selected species. The alignment was generated
using ClustalX (version 1.8). Identities (black shading) and
similarity groups (gray shading) were computed using Genedoc
(version 2.6.001) and the Blosum 62 scoring table. Percent identities
are shown to the right. An asterisk denotes
critical amino acids involved in saccharide binding. Drome,
Drosophila melanogaster galectin; mouse_gal-9,
Mus musculus galectin-9; human_gal-4, Homo
sapien galectin-4; Caeel_32kD, C. elegans
32-kDa galectin; Bufar_gal-1, Bufo arenarum
galectin-1; Conger lec1, Conger myriaster
galectin-1.
|
|
A BLAST search of the Berkeley Drosophila Genome Project
with the putative Dmgal amino acid sequence resulted in seven matches with a smallest sum probability value less than 0.5. One of the sequences was identical to the Dmgal sequence (GenBankTM
accession number AE003590) However, five of the remaining six sequences
lacked some of the amino acids considered critical for binding
-galactoside sugars (GenBankTM accession numbers
AE003590, AE003799, AE003588, AE003713, and AE003583) (34). Only one
sequence (GenBankTM accession number AE003514) contained
amino acids involved in -galactoside sugar recognition. However,
more studies are necessary to determine whether this is a true galectin
family member capable of binding -galactoside sugars.
Biochemical Characterization of Recombinant Dmgal--
The
defining feature of galectin family members is the ability to bind
-galactoside sugars (33). We expressed recombinant Dmgal with a
C-terminal His tag and asked if the protein would specifically bind to
a -lactose affinity column. The His-tagged Dmgal was not purified
over a nickel column prior to carbohydrate affinity chromatography
because this type of purification has been shown to be ineffective for
isolating active galectin.2 Therefore, the entire bacterial
supernatant was loaded directly on a -lactose or fucose affinity
column, and bound protein was eluted with -lactose or fucose,
respectively, and analyzed by immunoblotting with anti-His antibody. A
single band of 58 kDa, corresponding to the predicted molecular weight
of Dmgal, eluted from the -lactose column but not the fucose column
(Fig. 3A). This demonstrated
that Dmgal bound specifically to -galactoside sugars and confirmed
its identity as a galectin family member. Because all galectin family
members share structural similarities within their CRDs, we reasoned
that a polyclonal rabbit antibody specific for human galectin-1 might
cross-react with Dmgal. The anti-His blot was stripped and reprobed
with polyclonal rabbit anti-human galectin-1. As shown in Fig.
3A, the anti-human galectin-1 cross-reacted with Dmgal,
providing further evidence for strong structural similarities among
galectins from different species.

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 3.
Dmgal bound
-lactosyl-Sepharose and was expressed in embryonic,
larval, and adult Drosophila. A,
Dmgal bound -lactosyl-Sepharose but not fucosyl-Sepharose.
Lane 1, bacterial supernatant containing
His-tagged recombinant Dmgal was purified over a -lactosyl affinity
column and immunoblotted with anti-His antibody ( his).
Lane 2, the blot was stripped and probed with
polyclonal rabbit anti-human galectin-1 antibody
( galectin). Lane 3, recombinant
Dmgal was not detected within the eluate from a fucosyl-Sepharose
column with galectin (lane 3) or His (data
not shown) B, Dmgal was expressed in embryonic, larval,
and adult Drosophila. Soluble proteins were prepared from
Drosophila by Dounce homogenization in the presence of
-lactose, separated by 10% SDS-PAGE, and immunoblotted with
galectin. The entire lane is shown for each sample.
C, a single 1.5-kb mRNA for Dmgal was detected in
embryonic, larval, and adult Drosophila by Northern blot
hybridization. D, 58-kDa Dmgal was enriched in the
eluate from a -lactosyl-Sepharose column. Lane
1, Coomassie Blue staining of adult fly homogenate prior to
lactose affinity chromatography (load). Lane
2, Coomassie Blue staining of the unbound fraction
(unbound). Lane 3, Coomassie Blue
staining of the fraction specifically eluted with lactose
(eluate). Lane 4, Western blot
analysis with galectin of adult fly homogenate prior to lactose
affinity chromatography (load). Lane
5, Western blot analysis with galectin of the unbound
fraction (unbound). Lane 6, Western
blot analysis with galectin of the bound fraction from adult
Drosophila (eluate). Lane
7, Western blot analysis galectin of the bound fraction
from Drosophila larvae (eluate
(l)).
|
|
Dmgal Is Expressed in Embryonic, Larval, and Adult
Drosophila--
Because the anti-human galectin-1 antibody bound
Dmgal, we used this antibody as a reagent to determine the stage or
stages of Drosophila development where Dmgal was expressed.
5 µg of total protein homogenate from embryonic, third instar
larval and adult flies was separated by 10% SDS-PAGE and
immunoblotted with anti-human galectin-1 antibody. As shown in Fig.
3B, a prominent 58-kDa band was expressed at all three
stages. In addition, the Mr of native Dmgal matched the Mr of the predicted amino acid
sequence. This suggests that Dmgal is not glycosylated, consistent with
synthesis of galectin family members within the cytosol (47, 48).
We also examined expression of the Dmgal gene during specific
developmental stages by Northern blot hybridization.
Poly(A)+ RNA from embryonic, larval, and adult
Drosophila was probed with Dmgal cDNA. As shown in Fig.
3C, a single 1.5-kb mRNA for Dmgal was detected in
embryonic, larval, and adult Drosophila.
Examination of Native Dmgal--
To confirm that native Dmgal
bound -galactoside sugars and was recognized by anti-human
galectin-1 antibody, we isolated native galectin from adult and third
instar larvae protein homogenate by -lactose affinity chromatography
and eluted bound protein with -lactose. Immunoblotting with rabbit
anti-human galectin-1 polyclonal antibody revealed the 58-kDa Dmgal
band (Fig. 3D, lanes 6 and 7), demonstrating that
native Dmgal binds -lactose. Two additional bands of 38 and 72 kDa,
which were not seen on the anti-human galectin-1 Western blot of total
protein homogenate (Fig. 3B), were enriched by -lactose
affinity chromatography. These may represent additional
Drosophila galectins. Alternatively, these may represent
modified (49) or degraded Dmgal.
The total adult homogenate prior to affinity chromatography, the
unbound fraction, and the bound and eluted fraction were compared by
SDS-PAGE analysis (Fig. 3D, lanes 1-3), Western blotting (Fig. 3D, lanes 4-6), and protein assay (data not shown).
Western blot analysis with anti-human galectin-1 antibody showed Dmgal present in the load but not in the unbound fraction (Fig.
3D, lanes 4 and 5). There were no
significant differences between the load and unbound fractions by
Coomassie Blue staining (Fig. 3D) and or by quantification
of total protein (data not shown). This implies that only a minor
subset of proteins specifically bound to the affinity column. We were
unable to detect protein in the eluate by Coomassie Blue staining (Fig.
3D, lane 3) or by protein assay. However, by Western blot,
the 58-kDa Dmgal and two additional proteins that specifically bound to
and eluted from the -lactose column were evident (Fig. 3D,
lane 6). In addition, stripping and re-probing the blot with a
control antibody revealed that recognition of the proteins by the
anti-human galectin-1 antibody was specific (data not shown).
Dmgal Expression during
Embryogenesis--
-Galactoside-containing carbohydrate structures
were expressed in neural tissue during specific stages of
Drosophila embryogenesis (7, 8). The presence of
oligosaccharide ligands for galectins suggested that Dmgal might also
be present in the developing nervous system. Because galectins
participate in mammalian embryogenesis and brain development (24, 25),
we performed whole mount in situ hybridization on wild type
embryos to determine where and at which developmental stages Dmgal
cDNA was expressed. As shown in Fig.
4, Dmgal mRNA was deposited
maternally into the egg following fertilization. During gastrulation,
the presumptive mesoderm showed enriched expression of Dmgal mRNA.
In the elongated germ band embryo, Dmgal mRNA became strongly
expressed in the mesodermal and neural layers and in the invaginating
foregut and hindgut, whereas the epidermis showed weak Dmgal
expression. In stages 13-15, Dmgal expression was concentrated in the
central nervous system and in the somatic and visceral musculature. By
stage 16, Dmgal was expressed in somatic musculature, enriched in the
central nervous system (Fig. 4G), and not detected in the
visceral musculature (data not shown). Mammalian galectins mediate
cell-cell interactions during mammalian brain and muscle development
(24, 25, 50-52). In addition, mammalian galectins modulate cell
proliferation and cell survival, two processes that are essential in
the development of all organisms (22, 53-55). Because cell-cell
adhesion, cell proliferation, and cell survival are regulated during
embryogenesis and differentiation, Dmgal may participate in these
processes during Drosophila development.

View larger version (93K):
[in this window]
[in a new window]
|
Fig. 4.
Expression of Dmgal during
embryogenesis. Whole mount in situ hybridization of
Dmgal cDNA in wild type embryos. A, Dmgal mRNA
is deposited maternally into the egg (lateral view, stage 5).
B, during gastrulation, enriched expression of Dmgal
mRNA can be detected in the presumptive mesoderm (arrow)
(ventral view, stage 6). C, in the elongated germ band
embryo (lateral view, stage 10), Dmgal becomes strongly expressed in
the neural and mesodermal layer as well as in the invaginating foregut
and hindgut (arrows). In contrast, the presumptive epidermis
shows only weak Dmgal expression (arrowhead).
D-F, in developmental stages 13-15, Dmgal mRNA
becomes concentrated to the somatic and visceral musculature
(arrows) and the central nervous system
(arrowheads), ventral view (D and E);
dorsal view (F). G, at the end of
embryogenesis (stage 16, ventral view), Dmgal expression remains in the
somatic musculature (arrowhead) and becomes strongly
expressed in the central nervous system (arrow).
H, hybridization with a sense probe does not give any
detectable signal (stage 16, compare with G).
|
|
Dmgal Expression in the Drosophila Innate Immune System--
In
addition to developmental roles, galectins play key roles in adaptive
and innate immunity (20-23, 27, 28). The Drosophila immune
system consists of a humoral response of anti-microbial peptides from
the fat body and a cellular response from circulating hemocytes (2). We
did not detect expression of Dmgal in the fat body nor in larval lymph
glands, the tissues that produce hemocytes (data not shown). However,
as shown in Fig. 5, Dmgal was expressed
in circulating larval hemocytes. Interestingly, it appeared that all
isolated hemocytes displayed galectin labeling, suggesting that the
three major types of hemocytes, lammelocytes, plasmatocytes/macrophages, and crystal cells expressed galectin. In
addition, two distinct labeling patterns were observed (Fig. 5). In the
majority of hemocytes (73 ± 4.5%), galectin labeling was
localized in a large patch at one pole of the hemocyte (Fig. 5A). In the remaining hemocytes (27 ± 3.7%), galectin
was concentrated in multiple small patches throughout the cytosol (Fig.
5B). Because more than one band was detected by affinity
chromatography (Fig. 3D, lane 7), this staining
pattern may represent the localization of different galectins or
different forms of Dmgal (49). Alternatively, the staining pattern
observed in Drosophila hemocytes may represent the synthesis
and secretion pathway that has been described previously for mammalian
galectins (47, 48). In mammalian cells, galectins have a unique
synthesis and secretion pattern (47, 48). This unique secretion pathway
is characterized by synthesis of galectin within the cytosol,
concentration of galectin patches at the perimeter of the cell, and
evagination of galectin into vesicles that are released from the cell
(47, 48).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 5.
Two distinct Dmgal labeling patterns were
observed in larval hemocytes. A, in the majority
of hemocytes Dmgal (green) was localized in a large patch at
one pole of the cell. One 0.5-µm slice each of three different cells
are shown. B, in the remainder of the hemocytes, Dmgal
(green) was localized in multiple small concentrations
throughout the cytosol. One 0.5-µm slice each of three different
cells are shown. C, localization of Dmgal
(green) on three consecutive 0.5-µm slices of a single
hemocyte. D, control hemocytes, incubated with
preimmune rabbit serum, showed no reactivity. Left,
phase-contrast microscopy. Right, confocal microscopy.
All cells were analyzed using the ×100 objective.
|
|
 |
DISCUSSION |
We have identified the first galectin in D. melanogaster. Dmgal shows striking sequence similarity to
vertebrate galectins and possesses critical amino acids that are
involved in carbohydrate binding (33). Dmgal binds -galactoside
sugars, confirming its identity as a galectin family member
(33). Structurally, Dmgal contains two CRDs per molecule, suggesting
that, like mammalian galectins, Dmgal may mediate cell-cell
communication or trigger signal transduction events (22, 53-55). Dmgal
had highest sequence similarity to mammalian galectin-4 and galectin-9.
Galectin-9 can trigger apoptosis of cells in the immune system (38).
Galectin-9 has also recently been shown to be identical to the
mammalian urate transporter, implying that galectins may have multiple
functions (56, 57). The conservation of galectins in species ranging from multicellular fungi (58) and sponges (59) to humans provides further evidence of a critical role for galectins in mediating cell-cell communication in all multicellular organisms.
Dmgal was abundant in embryonic, larval, and adult
Drosophila. As shown in Fig. 3B, the 58-kDa Dmgal
band was prominent, with no additional purification steps, in only 5 µg of embryonic, larval, and adult total protein homogenate.
Galectins are abundant in the many tissues where they are expressed; in
lizard, for example, a 14-kDa galectin consists of 25 µg/g of wet
tissue (16). The abundant expression of the 58-kDa galectin in
Drosophila suggests that it may have basic and important
functions that are common to many cell types.
Cell surface carbohydrates have been proposed to function in cellular
recognition events during embryogenesis, because the synthesis and
presentation of diverse carbohydrate structures are spatially and
temporally regulated during development (7, 8, 60, 61). In addition,
carbohydrate modifications during Drosophila embryogenesis
have been shown to regulate the activity of developmental proteins such
as Notch, allowing Notch to be spatially activated along a discrete
boundary of cells (62, 63). Lectins are postulated to participate in
the cellular interactions necessary for development by recognizing
complementary glycoconjugates expressed on cells or in the
extracellular matrix.
Dmgal had a unique and specific tissue distribution during embryonic
development. During gastrulation, galectin was expressed within the
invaginating ventral furrow that forms the mesodermal layer. Later in
embryogenesis, galectin was strongly expressed in the mesodermal and
neural layer and in the invaginating foregut and hindgut.
Interestingly, the mesoderm forms somatic and visceral muscle,
connective tissue, and endothelium, tissues that are known to express
galectins in mammals (21, 22, 64). In addition, the mesoderm also forms
components of the Drosophila innate immune system, namely
the fat body, lymph glands, and hemocytes (2). In mammals, galectins
are expressed in lymphoid organs and play important roles in the innate
and adaptive immune systems (20-23, 27, 28).
As embryogenesis continued, Dmgal expression was concentrated in the
somatic and visceral musculature and in the central nervous system. The
presence of galectin in Drosophila musculature suggests that
it may mediate cell-cell and cell-matrix interactions that are required
for muscle development. During chick muscle development, galectin
appears at stages of myotome segregation and reaches high levels during
muscle differentiation (51, 65). In chick muscle, galectin is also
proposed to modulate adhesion to the extracellular matrix during
myoblast fusion (51). Dmgal may have similar functions during
Drosophila muscle development.
The expression of Dmgal was also enriched in the central nervous
system. Studies of glyconjugate expression during Drosophila development demonstrated that possible galactoside-containing carbohydrate ligands for Dmgal are present in the developing tracts of
the ventral nerve cord and on axons and glia that ensheath neurons and
appose the axon tracts (7, 8). Dmgal could represent a receptor for
these glycoconjugates and facilitate axon guidance or fasciculation.
Furthermore, laminin is also present around developing glia and axons
in the Drosophila nervous system (66). Laminin has been
shown previously to bind galectin (67) and may be an extracellular
matrix protein that Dmgal can bind during neural development. In
galectin-1 / mice, intriguing deficits in olfactory axon
pathfinding during neural development have been reported (24). In
addition, galectin-1 and galectin-3 are transiently expressed by a
subset of murine dorsal root ganglia and have been proposed to mediate
interactions necessary for axonal fasciculation (24, 68). Dmgal may
also mediate cell-cell interactions and migration in
Drosophila neural development.
Many insect and mammalian lectins play dual roles in development and in
immune defense (1, 13, 22, 23). The Sarcophaga C-type lectin
has a potential role in wing and leg imaginal disc development and is
also secreted into the hemolymph following injury (13). The dual roles
of lectins in development and immunity are similar to the dual roles of
the pattern recognition receptor Toll in the establishment of the
dorso-ventral axis in embryogenesis and in the immune response (69). In
mammals, galectin family members participate in development and in the
innate and adaptive immune systems (20-23, 27, 28). Interestingly, a
putative galectin homologue was up-regulated in Anopheles
mosquitoes following an immune challenge (12), suggesting that
galectins participate in insect innate immunity.
Dmgal may also function in both development and in innate immunity. We
found that Drosophila hemocytes express galectin. Hemocytes play vital roles in insect immunity by synthesizing anti-microbial peptides and phagocytosing microorganisms (2). On these cells, galectin
was localized in cytoplasmic concentrations and in a large polar patch,
suggesting that galectin may participate in recognition or phagocytosis
of microorganisms. Whereas galectins are not typically thought to bind
to sugars found on microbial cells, mammalian galectin-3 expressed by
macrophages binds Candida albicans (70) and bacterial
lipopolysaccharide (71, 72), and galectin-3 was present in macrophage
phagosomes (73). Alternatively, because Dmgal is a tandem repeat
galectin and thus divalent, Dmgal may modulate hemocyte aggregation
during infection. In mammals and sponges, galectins can also trigger an
alternative complement activation pathway, a host defense system that
may be conserved in Drosophila (74). Intracellular Dmgal may
also be released from hemocytes upon immune challenge, because
galectin-10 is released from eosinophils after stimulation (75) and
galectin-3 is released from dendritic cell exosomes during antigen
presentation (76).
We have cloned and characterized the first galectin family member from
Drosophila (15). Genetic manipulation is a powerful tool for
the study of protein function in vivo. The presence of a
galectin homologue in Drosophila (15) will facilitate the elucidation of galectin functions in various organ systems during development and immune challenge.
 |
ACKNOWLEDGEMENTS |
We thank U. Banerjee, D. Gunning,
J. Hernandez, C. Lee, J. Nguyen, M. Pang, A. Reynolds, D. Schmucker, and S. L. Zipursky for valuable advice and technical
assistance and J. Rini for critical reading of the manuscript.
 |
FOOTNOTES |
*
This work was supported by Grant AI40118 from the National
Institutes of Health (to L. G. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF338142.
**
To whom correspondence should be addressed. Tel.: 310-206-5985;
Fax: 310-206-0657; E-mail: lbaum@mednet.ucla.edu.
Published, JBC Papers in Press, January 24, 2002, DOI 10.1074/jbc.M112105200
2
J. C. LeFebvre and L. G. Baum,
unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
Dmgal, Drosophila melanogaster galectin;
RACE, rapid amplification
of cDNA ends;
GSP, gene-specific primer;
EST, expressed sequence
tag;
DTT, dithiothreitol;
ECL, enhanced chemiluminescence;
CRD, carbohydrate recognition domain.
 |
REFERENCES |
| 1.
|
Franc, N. C.,
and White, K.
(2000)
Microbes Infect.
2,
243-250[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Vilmos, P.,
and Kurucz, E.
(1998)
Immunol. Lett.
62,
59-66[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Haq, S.,
Kubo, T.,
Shoichiro, K.,
Kobayashi, A.,
and Natori, S.
(1996)
J. Biol. Chem.
271,
20213-20218[Abstract/Free Full Text]
|
| 4.
|
Tiemeyer, M.,
and Goodman, C. S.
(1996)
Development
122,
925-936[Abstract]
|
| 5.
|
Leshko-Lindsay, L.,
and Corces, V. G.
(1997)
Development
124,
169-180[Abstract]
|
| 6.
|
Seppo, A.,
and Tiemeyer, M.
(2000)
Glycobiology
10,
751-760[Abstract/Free Full Text]
|
| 7.
|
D'Amico, P.,
and Jacobs, J. R.
(1995)
Tissue & Cell
27,
23-30[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Fredieu, J. R.,
and Mahowald, A. P.
(1994)
Acta Anat.
149,
89-99[Medline]
[Order article via Infotrieve]
|
| 9.
|
Tabuchi, K.,
Sawamoto, K.,
Suzuki, E.,
Ozaki, K.,
Sonc, M.,
Hama, C.,
Tanifuji-Morimoto, T.,
Yuasa-Yoshihara, Y.,
Nose, A.,
and Okano, M.
(2000)
J. Neurosci. Res.
59,
94-99[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Fristrom, D. K.,
and Fristrom, J. W.
(1982)
Dev. Biol.
92,
418-427[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Hoffman, J. A.,
Kafatos, F. C.,
Janeway, C. A., Jr.,
and Ezekowitz, R. A. B.
(1999)
Science
284,
1313-1318[Abstract/Free Full Text]
|
| 12.
|
Dimopoulos, G.,
Richman, A.,
Müller, H. M.,
and Kafatos, F. C.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
11508-11513[Abstract/Free Full Text]
|
| 13.
|
Fujita, Y.,
Kurata, S.,
Homma, K.-I.,
and Natori, S.
(1998)
J. Biol. Chem.
273,
9667-9672[Abstract/Free Full Text]
|
| 14.
|
Theopold, U.,
Rissler, M.,
Fabbri, M.,
Schmidt, O.,
and Natori, S.
(1999)
Biochem. Biophys. Res. Commun.
261,
923-927[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Cooper, D. N. W.,
and Barondes, S. H.
(1999)
Glycobiology
9,
979-984[Free Full Text]
|
| 16.
|
Solís, D.,
López-Lucendo, M. I. F.,
León, S.,
Varela, J.,
and Díaz-Mauriño, T.
(2000)
Glycobiology
10,
1325-1331[Abstract/Free Full Text]
|
| 17.
|
Hotta, K.,
Funahashi, T.,
Matsukawa, Y.,
Takahashi, M.,
Nishizawa, H.,
Kishida, K.,
Matsuda, M.,
Kuriyama, H.,
Kihara, S.,
Nakamura, T.,
Tochino, Y.,
Bodkin, N. L.,
Hansen, B. C.,
and Matsuzawa, Y.
(2001)
J. Biol. Chem.
276,
34089-34097[Abstract/Free Full Text]
|
| 18.
|
Yang, R.-Y.,
Hsu, D. K., Yu, L., Ni, J.,
and Liu, F.-T.
(2001)
J. Biol. Chem.
276,
20252-20260[Abstract/Free Full Text]
|
| 19.
|
Visegrady, B.,
Than, N. G.,
Kilar, F.,
Sumegi, B.,
Than, G. N.,
and Bohn, H.
(2001)
Protein Eng.
14,
875-880[Abstract/Free Full Text]
|
| 20.
|
Pace, K. E.,
and Baum, L. G.
(1997)
Trends Glycosci. Glycotechnol.
9,
21-29
|
| 21.
|
Perillo, N. L.,
Marcus, M. E.,
and Baum, L. G.
(1998)
J. Mol. Med.
76,
402-412[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Liu, F.-T.
(2000)
Clin. Immunol.
97,
79-88[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Rabinovich, G. A.
(1999)
Cell Death Differ.
6,
711-721[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Puche, A. C.,
Poirier, F.,
Hair, M.,
Bartlett, P. F.,
and Keys, B.
(1996)
Dev. Biol.
179,
274-287[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Mahanthappa, N. K.,
Cooper, D. N. W.,
Barondes, S. H.,
and Schwarting, G. A.
(1994)
Development
120,
1373-1384[Abstract]
|
| 26.
|
Perillo, N. L.,
Uittenbogaart, C. H.,
Nguyen, J. T.,
and Baum, L. G.
(1997)
J. Exp. Med.
185,
1851-1858[Abstract/Free Full Text]
|
| 27.
|
Vasta, G. R.,
Quesenberry, M.,
Ahmed, H.,
and O'Leary, N.
(1999)
Dev. Comp. Immunol.
23,
401-420[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Demetriou, M.,
Granovsky, M.,
Quaggin, S.,
and Dennis, J. W.
(2001)
Nature
409,
733-739[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Pace, K. E.,
Lee, C.,
Stewart, P. L.,
and Baum, L. G.
(1999)
J. Immunol.
163,
3801-3811[Abstract/Free Full Text]
|
| 30.
|
Hirabayashi, J.,
Satoh, M.,
and Kasai, K.
(1992)
J. Biol. Chem.
267,
15485-15490[Abstract/Free Full Text]
|
| 31.
|
Dong, X.,
Tsuda, L.,
Zavitz, K. H.,
Lin, M.,
and Zipursky, S. L.
(1999)
Genes Dev.
13,
954-965[Abstract/Free Full Text]
|
| 32.
|
Adams, M. D.,
Celniker, S. E.,
Holt, R. A.,
Evans, C. A.,
Gocayne, J. D.,
Amanatides, P. G.,
Scherer, S. E., Li, P. W.,
Hoskins, R. A.,
Galle, R. F.,
et al..
(2000)
Science
287,
2185-2195[Abstract/Free Full Text]
|
| 33.
|
Barondes, S. H.,
Castronovo, V.,
Cooper, D. N. W.,
Cummings, R. D.,
Hirabayashi, J.,
Hughes, C.,
Kasai, K.-I.,
Leffler, H.,
and Liu, F.-T.
(1994)
Cell
76,
597-598[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Bournes, Y.,
Bolgiano, B.,
Liao, D.-I.,
Strecker, G.,
Cantau, P.,
Herzberg, O.,
Feizi, T.,
and Cambillau, C.
(1994)
Nat. Struct. Biol.
1,
863-870[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Hirabayashi, J.,
and Kasai, K.-I.
(1993)
Glycobiology
3,
297-304[Abstract/Free Full Text]
|
| 36.
|
Oda, Y.,
Herrman, J.,
Gitt, M. A.,
Turck, C. W.,
Burlingame, A. L.,
Barondes, S.,
and Leffler, H.
(1993)
J. Biol. Chem.
268,
5929-5939[Abstract/Free Full Text]
|
| 37.
|
Hadari, Y. R.,
Paz, K.,
Dekel, R.,
Mestrovic, T.,
Accili, D.,
and Zick, Y.
(1995)
J. Biol. Chem.
270,
3447-3453[Abstract/Free Full Text]
|
| 38.
|
Wada, K.,
and Kanwar, Y. S.
(1997)
J. Biol. Chem.
272,
6078-6086[Abstract/Free Full Text]
|
| 39.
|
Gitt, M. A.,
Wiser, M. F.,
Leffler, H.,
Herrmann, J.,
Xia, Y. R.,
Massa, S. M.,
Cooper, D. N.,
Lusis, A. J.,
and Barondes, S. H.
(1995)
J. Biol. Chem.
270,
5032-5038[Abstract/Free Full Text]
|
| 40.
|
Lobsanov, Y. D.,
Gitt, M. A.,
Leffler, H.,
Barondes, S. H.,
and Rini, J. M.
(1993)
J. Biol. Chem.
268,
27034-27038[Abstract/Free Full Text]
|
| 41.
|
Marschal, P.,
Herrmann, J.,
Leffler, H.,
Barondes, S. H.,
and Cooper, D. N. W.
(1992)
J. Biol. Chem.
267,
12942-12949[Abstract/Free Full Text]
|
| 42.
|
Pfeifer, K.,
Haasemann, M.,
Gamulin, V.,
Bretting, H.,
Fahrenholz, F.,
and Müller, W. E. G.
(1993)
Glycobiology
3,
179-184[Abstract/Free Full Text]
|
| 43.
|
Geourjon, C.,
and Deléage, G.
(1994)
Protein Eng.
7,
157-164[Abstract/Free Full Text]
|
| 44.
|
Rechreche, H.,
Mallo, G. V.,
Montalto, G.,
Dagorn, J. C.,
and Iovanna, J. L.
(1997)
Eur. J. Biochem.
248,
225-230[Medline]
[Order article via Infotrieve]
|
| 45.
|
Levi, G.,
and Teichberg, V. I.
(1981)
J. Biol. Chem.
256,
5735-5740[Abstract/Free Full Text]
|
| 46.
|
Ahmed, H.,
Pohl, J.,
Fink, N. E.,
Strobel, F.,
and Vasta, G. R.
(1996)
J. Biol. Chem.
271,
3308-33094
|
| 47.
|
Harrison, F. L.,
and Wilson, T. J.
(1992)
J. Cell Sci.
101,
635-646[Abstract/Free Full Text]
|
| 48.
|
Hughes, R. C.
(1999)
Biochim. Biophys. Acta
1473,
172-185[Medline]
[Order article via Infotrieve]
|
| 49.
|
Yoshii, T.,
Fukumori, T.,
Honjo, Y.,
Inohara, H.,
Kim, H.-R.,
and Raz, A.
(2001)
J. Biol. Chem.
277,
6852-6857[Medline]
[Order article via Infotrieve]
|
| 50.
|
Gu, M.,
Wang, W.,
Song, W. K.,
Cooper, D. N.,
and Kaufman, S. J.
(1994)
J. Cell Sci.
107,
175-181[Abstract]
|
| 51.
|
Cooper, D. N. W.,
Massa, S. M.,
and Barondes, S. H.
(1991)
J. Cell Biol.
115,
1437-1448[Abstract/Free Full Text]
|
| 52.
|
Moiseeva, E. P.,
Javed, Q.,
Spring, E. I.,
and de Bono, D. P.
(2000)
Cardiovasc. Res.
45,
493-502[Abstract/Free Full Text]
|
| 53.
|
Hadari, Y. R.,
Arbel-Goren, R.,
Levy, Y.,
Amsterdam, A.,
Alon, R.,
Zakut, R.,
and Zick, Y.
(2000)
J. Cell Sci.
113,
2385-2397[Abstract]
|
| 54.
|
Pace, K. E.,
Hahn, H. P.,
Pang, M.,
Nguyen, J. T.,
and Baum, L. G.
(2000)
J. Immunol.
165,
2331-2334[Abstract/Free Full Text]
|
| 55.
|
Baum, L. G.,
Pang, M.,
Perillo, N. L., Wu, T.,
Delegeane, A.,
Uittenbogaart, C. H.,
Fukuda, M.,
and Seilhammer, J.
(1995)
J. Exp. Med.
181,
877-887[Abstract/Free Full Text]
|
| 56.
|
Leal-Pinto, E.,
Cohen, B. E.,
and Abramson, R. G.
(1999)
J. Membr. Biol.
169,
13-27[CrossRef][Medline]
[Order article via Infotrieve]
|
| 57.
|
Lipkowitz, M. S.,
Leal-Pinto, E.,
Rappoport, J. Z.,
Najfeld, V.,
and Abramson, R. G.
(2001)
J. Clin. Invest.
107,
1103-1115[Medline]
[Order article via Infotrieve]
|
| 58.
|
Cooper, D. N. W,
Boulianne, R. P.,
Charlton, S.,
Farrell, E. M.,
Sucher, A.,
and Lu, B. C.
(1997)
J. Biol. Chem.
272,
1514-1521[Abstract/Free Full Text]
|
| 59.
|
Wagner-Hülsmann, C.,
Bachinski, N.,
Diehl-Seifert, B.,
Blumbach, B.,
Steffen, R.,
Pancer, Z.,
and Müller, W. E. G.
(1996)
Glycobiology
6,
785-793[Abstract/Free Full Text]
|
| 60.
|
Mann, P. L.,
and Waterman, R. E.
(1998)
Acta Anat.
161,
153-161[CrossRef][Medline]
[Order article via Infotrieve]
|
| 61.
|
Hacker, U.,
Lin, X.,
and Perrimon, N.
(1997)
Development
124,
3565-3573[Abstract]
|
| 62.
|
Moloney, D. J.,
Panin, V. M.,
Johnston, S. H.,
Chen, J.,
Shao, L.,
Wilson, R.,
Wang, Y.,
Stanley, P.,
Irvine, K. D.,
Haltiwanger, R. S.,
and Vogt, T. F.
(2000)
Nature
406,
369-375[CrossRef][Medline]
[Order article via Infotrieve]
|
| 63.
|
Brückner, K.,
Perez, L.,
Clausen, H.,
and Cohen, S.
(2000)
Nature
406,
411-415[CrossRef][Medline]
[Order article via Infotrieve]
|
| 64.
|
Chiariotti, L.,
Salvatore, P.,
Benvenuto, G.,
and Bruni, C. B.
(1999)
Biochimie (Paris)
81,
331-388
|
| 65.
|
Cooper, D. N. W.,
and Barondes, S. H.
(1990)
J. Cell Biol.
110,
1681-1691[Abstract/Free Full Text]
|
| 66.
|
Montell, D. J.,
and Goodman, C. S.
(1989)
J. Cell Biol.
109,
2441-2453[Abstract/Free Full Text]
|
| 67.
|
Zhou, Q.,
and Cummings, R. D.
(1993)
Arch. Biochem. Biophys.
300,
6-17[CrossRef][Medline]
[Order article via Infotrieve]
|
| 68.
|
Fowlis, D.,
Colnot, C.,
Ripoche, M. A.,
and Poirier, F.
(1995)
Dev. Dyn.
203,
241-251[Medline]
[Order article via Infotrieve]
|
| 69.
|
Vogel, G.
(1998)
Science
281,
1942-1944[Free Full Text]
|
| 70.
|
Fradin, C.,
Poulain, D.,
and Jouault, T.
(2000)
Infect. Immun.
68,
4391-4398[Abstract/Free Full Text]
|
| 71.
|
Loukas, A.,
and Maizels, R. M.
(2000)
Parasitol. Today
16,
333-339[CrossRef][Medline]
[Order article via Infotrieve]
|
| 72.
|
Mey, A.,
Leffler, H.,
Hmama, G.,
Normier, G.,
and Revillard, J. P.
(1996)
J. Immunol.
156,
1572-1577[Abstract]
|
| 73.
|
Garin, J.,
Diez, R.,
Kieffer, S.,
Dermine, J.-F.,
Duclos, S.,
Gagnon, E.,
Sadoul, R.,
Rondeau, C.,
and Desjardins, M.
(2001)
J. Cell Biol.
152,
165-180[Abstract/Free Full Text]
|
| 74.
|
Lagueux, M.,
Perrodou, E.,
Levashina, E. A.,
Capovilla, M.,
and Hoffmann, J. A.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
11427-11432[Abstract/Free Full Text]
|
| 75.
|
Leonidas, D. D.,
Elbert, B. L.,
Zhou, Z.,
Leffler, H.,
Ackerman, S. J.,
and Acharya, K. R.
(1995)
Structure
3,
1379-1393[Medline]
[Order article via Infotrieve]
|
| 76.
|
Théry, C.,
Boussac, M.,
Véron, P.,
Ricciardi-Castagnoli, P.,
Raposo, G.,
Garin, J.,
and Amigorena, S.
(2001)
J. Immunol.
166,
7309-7318[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Yoshida, T. J Fuwa, M. Arima, H. Hamamoto, N. Sasaki, T. Ichimiya, K.-i. Osawa, R. Ueda, and S. Nishihara
Identification of the Drosophila core 1 {beta}1,3-galactosyltransferase gene that synthesizes T antigen in the embryonic central nervous system and hemocytes
Glycobiology,
December 1, 2008;
18(12):
1094 - 1104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Takeuchi, K. Hayama, J. Hirabayashi, and K.-i. Kasai
Caenorhabditis elegans N-glycans containing a Gal-Fuc disaccharide unit linked to the innermost GlcNAc residue are recognized by C. elegans galectin LEC-6
Glycobiology,
November 1, 2008;
18(11):
882 - 890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Huang, N. Tsuji, T. Miyoshi, S. Nakamura-Tsuruta, J. Hirabayashi, and K. Fujisaki
Molecular characterization and oligosaccharide-binding properties of a galectin from the argasid tick Ornithodoros moubata
Glycobiology,
March 1, 2007;
17(3):
313 - 323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Kohatsu, D. K. Hsu, A. G. Jegalian, F.-T. Liu, and L. G. Baum
Galectin-3 Induces Death of Candida Species Expressing Specific beta-1,2-Linked Mannans
J. Immunol.,
October 1, 2006;
177(7):
4718 - 4726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Vergote, P.-E. Sautiere, F. Vandenbulcke, D. Vieau, G. Mitta, E. R. Macagno, and M. Salzet
Up-regulation of Neurohemerythrin Expression in the Central Nervous System of the Medicinal Leech, Hirudo medicinalis, following Septic Injury
J. Biol. Chem.,
October 15, 2004;
279(42):
43828 - 43837.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Houzelstein, I. R. Goncalves, A. J. Fadden, S. S. Sidhu, D. N. W. Cooper, K. Drickamer, H. Leffler, and F. Poirier
Phylogenetic Analysis of the Vertebrate Galectin Family
Mol. Biol. Evol.,
July 1, 2004;
21(7):
1177 - 1187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ahmed, S.-J. Du, N. O'Leary, and G. R. Vasta
Biochemical and molecular characterization of galectins from zebrafish (Danio rerio): notochord-specific expression of a prototype galectin during early embryogenesis
Glycobiology,
March 1, 2004;
14(3):
219 - 232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Pelletier, T. Hashidate, T. Urashima, N. Nishi, T. Nakamura, M. Futai, Y. Arata, K.-i. Kasai, M. Hirashima, J. Hirabayashi, et al.
Specific Recognition of Leishmania major Poly-{beta}-galactosyl Epitopes by Galectin-9: POSSIBLE IMPLICATION OF GALECTIN-9 IN INTERACTION BETWEEN L. MAJOR AND HOST CELLS
J. Biol. Chem.,
June 13, 2003;
278(25):
22223 - 22230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Takemae, R. Ueda, R. Okubo, H. Nakato, S. Izumi, K. Saigo, and S. Nishihara
Proteoglycan UDP-Galactose:beta -Xylose beta 1,4-Galactosyltransferase I Is Essential for Viability in Drosophila melanogaster
J. Biol. Chem.,
April 25, 2003;
278(18):
15571 - 15578.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|